# Phase 1 Study of MGD010 in Healthy Subjects

> **NCT02376036** · PHASE1 · COMPLETED · sponsor: **MacroGenics** · enrollment: 73 (actual)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** MGD010
- **DRUG:** Placebo
- **BIOLOGICAL:** Hepatitis A vaccine

## Key facts

- **NCT ID:** NCT02376036
- **Lead sponsor:** MacroGenics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02
- **Primary completion:** 2017-02
- **Final completion:** 2017-02
- **Target enrollment:** 73 (ACTUAL)
- **Last updated:** 2022-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02376036

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02376036, "Phase 1 Study of MGD010 in Healthy Subjects". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02376036. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*